ID: ALA60048

Max Phase: Preclinical

Molecular Formula: C24H32N2O4

Molecular Weight: 412.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc2c(cc1OC)CN(CCCCNC(=O)c1cc(C)ccc1OC)CC2

Standard InChI:  InChI=1S/C24H32N2O4/c1-17-7-8-21(28-2)20(13-17)24(27)25-10-5-6-11-26-12-9-18-14-22(29-3)23(30-4)15-19(18)16-26/h7-8,13-15H,5-6,9-12,16H2,1-4H3,(H,25,27)

Standard InChI Key:  KOEMMHBJOHMMBF-UHFFFAOYSA-N

Associated Targets(Human)

SIGMAR1 Tclin Sigma opioid receptor (6358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TMEM97 Tchem Sigma intracellular receptor 2 (973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd3 Dopamine D3 receptor (1050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sigmar1 Sigma opioid receptor (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 412.53Molecular Weight (Monoisotopic): 412.2362AlogP: 3.59#Rotatable Bonds: 9
Polar Surface Area: 60.03Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.00CX LogP: 3.45CX LogD: 2.75
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.64Np Likeness Score: -0.94

References

1. Mach RH, Huang Y, Freeman RA, Wu L, Vangveravong S, Luedtke RR..  (2004)  Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligands.,  14  (1): [PMID:14684327] [10.1016/j.bmcl.2003.09.083]
2. Colabufo NA, Abate C, Contino M, Inglese C, Ferorelli S, Berardi F, Perrone R..  (2008)  Tritium radiolabelling of PB28, a potent sigma-2 receptor ligand: pharmacokinetic and pharmacodynamic characterization.,  18  (6): [PMID:18178434] [10.1016/j.bmcl.2007.12.056]
3. Mach RH, Zeng C, Hawkins WG..  (2013)  The σ2 receptor: a novel protein for the imaging and treatment of cancer.,  56  (18): [PMID:23734634] [10.1021/jm301545c]
4. Bai S, Li S, Xu J, Peng X, Sai K, Chu W, Tu Z, Zeng C, Mach RH..  (2014)  Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues as σ2 receptor ligands.,  57  (10): [PMID:24821398] [10.1021/jm5001453]
5. Sun YT, Wang GF, Yang YQ, Jin F, Wang Y, Xie XY, Mach RH, Huang YS..  (2018)  Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.,  147  [PMID:29438891] [10.1016/j.ejmech.2017.11.016]
6. Xie XY,Li YY,Ma WH,Chen AF,Sun YT,Lee JY,Riad A,Xu DH,Mach RH,Huang YS.  (2021)  Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σR/TMEM97 ligands.,  209  [PMID:33049607] [10.1016/j.ejmech.2020.112906]

Source